Get started
IPSENIPSENIPSEN

IPSEN

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

IPN chart


Full chart

IPN upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪9.36 B‬ EUR
Dividend yield (indicated)
1.06%
Price to earnings Ratio (TTM)
13.8
Basic EPS (TTM)
8.2 EUR
Net income (FY)
‪644.40 M‬ EUR
Revenue (FY)
‪3.13 B‬ EUR
Shares float
‪34.73 M‬
Beta (1Y)
0.18

Employees


Employees (FY)
‪5.33 K‬
Change (1Y)
+253 +4.99%
Revenue / Employee (1Y)
‪648.25 K‬ EUR
Net income / Employee (1Y)
‪127.91 K‬ EUR

About IPSEN


Sector
Health Technology
CEO
David G. Loew
Headquarters
Boulogne-Billancourt
Website
ipsen.com
Founded
1998
ISIN
FR0010259150
FIGI
BBG00X8QK311
Ipsen SA manufactures pharmaceutical products for oncology, neuroscience, and rare diseases. It operates through the following segments: Specialty Care. The Specialty Care segment focuses on oncology with Somatuline, a somatostatin analog for the treatment of neuroendocrine tumors; Cabometyx, the single-agent treatment with significant improvement across all key efficacy endpoints in second-line renal cell carcinoma; Onivyde, a differentiated product with overall survival benefit addressing a high unmet medical need in pancreatic cancer; and Decapeptyl, an established and growing product in Europe and China for prostate cancer and rare diseases with Nutropin, a liquid formulation of recombinant human growth hormone and Increlex, a recombinant insulin-like growth factor of human origin. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

IPN news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of IPN is 112.2 EUR — it has decreased by −0.09% in the past 24 hours. Watch IPSEN stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange IPSEN stocks are traded under the ticker IPN.
IPN stock has fallen by −2.34% compared to the previous week, the month change is a −0.09% fall, over the last year IPSEN has showed a 1.91% increase.
We've gathered analysts' opinions on IPSEN future price: according to them, IPN price has a max estimate of 166.00 EUR and a min estimate of 110.00 EUR. Watch IPN chart and read a more detailed IPSEN stock forecast: see what analysts think of IPSEN and suggest that you do with its stocks.
IPN reached its all-time high on Sep 18, 2023 with the price of 128.3 EUR, and its all-time low was 66.7 EUR and was reached on Mar 12, 2021. View more price dynamics on IPN chart.
See other stocks reaching their highest and lowest prices.
IPN stock is 1.07% volatile and has beta coefficient of 0.18. Track IPSEN stock price on the chart and check out the list of the most volatile stocks — is IPSEN there?
Today IPSEN has the market capitalization of ‪9.30 B‬, it has increased by 0.18% over the last week.
Yes, you can track IPSEN financials in yearly and quarterly reports right on TradingView.
IPSEN is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
IPN net income for the last half-year is ‪232.00 M‬ EUR, while the previous report showed ‪449.20 M‬ EUR of net income which accounts for −48.35% change. Track more IPSEN financial stats to get the full picture.
Yes, IPN dividends are paid annually. The last dividend per share was 1.20 EUR. As of today, Dividend Yield (TTM)% is 1.07%. Tracking IPSEN dividends might help you take more informed decisions.
IPSEN dividend yield was 1.11% in 2023, and payout ratio reached 15.40%. The year before the numbers were 1.19% and 15.25% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 5, 2024, the company has ‪5.33 K‬ employees. See our rating of the largest employees — is IPSEN on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IPSEN EBITDA is ‪1.38 B‬ EUR, and current EBITDA margin is 30.23%. See more stats in IPSEN financial statements.
Like other stocks, IPN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IPSEN stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IPSEN technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IPSEN stock shows the buy signal. See more of IPSEN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.